119 related articles for article (PubMed ID: 7499022)
1. Lentinan augments skin reaction induced by bradykinin: its correlation with vascular dilatation and hemorrhage responses and antitumor activities.
Takatsuki F; Namiki R; Kikuchi T; Suzuki M; Hamuro J
Int J Immunopharmacol; 1995 Jun; 17(6):465-74. PubMed ID: 7499022
[TBL] [Abstract][Full Text] [Related]
2. Four dominant loci for the vascular responses by the antitumor polysaccharide, lentinan.
Maeda YY; Takahama S; Yonekawa H
Immunogenetics; 1998; 47(2):159-65. PubMed ID: 9396862
[TBL] [Abstract][Full Text] [Related]
3. Antitumor and immunological activity of lentinan in comparison with LPS.
Suzuki M; Takatsuki F; Maeda YY; Hamuro J; Chihara G
Int J Immunopharmacol; 1994; 16(5-6):463-8. PubMed ID: 7927994
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of anti-tumor effects of lentinan in nude mice: roles of delayed-type hypersensitivity reaction triggered by CD4-positive T cell clone in the infiltration of effector cells into tumor.
Suzuki M; Iwashiro M; Takatsuki F; Kuribayashi K; Hamuro J
Jpn J Cancer Res; 1994 Apr; 85(4):409-17. PubMed ID: 7911123
[TBL] [Abstract][Full Text] [Related]
5. T-cell mediated vascular dilatation and hemorrhage induced by antitumour polysaccharides.
Maeda YY; Watanabe ST; Chihara G; Rokutanda M
Int J Immunopharmacol; 1984; 6(5):493-501. PubMed ID: 6334043
[TBL] [Abstract][Full Text] [Related]
6. Polygenic control of the expression of biological activities of an antitumor polysaccharide, lentinan.
Maeda YY; Takahama S; Kohara Y; Yonekawa H
Int J Immunopharmacol; 1997; 19(9-10):469-72. PubMed ID: 9637340
[TBL] [Abstract][Full Text] [Related]
7. Curative effects of combination therapy with lentinan and interleukin-2 against established murine tumors, and the role of CD8-positive T cells.
Suzuki M; Kikuchi T; Takatsuki F; Hamuro J
Cancer Immunol Immunother; 1994 Jan; 38(1):1-8. PubMed ID: 8299113
[TBL] [Abstract][Full Text] [Related]
8. Genetic control of the expression of two biological activities of an antitumor polysaccharide, lentinan.
Maeda YY; Sakaizumi M; Moriwaki K; Yonekawa H
Int J Immunopharmacol; 1991; 13(7):977-86. PubMed ID: 1722195
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes).
Ng ML; Yap AT
J Altern Complement Med; 2002 Oct; 8(5):581-9. PubMed ID: 12470439
[TBL] [Abstract][Full Text] [Related]
10. Changes of antitumor immunity of hosts with murine mammary tumors regressed by lentinan: potentiation of antitumor delayed hypersensitivity reaction.
Masuko Y; Nakajima H; Tsubouchi J; Yamazaki M; Mizuno D; Abe S
Gan; 1982 Oct; 73(5):790-7. PubMed ID: 7166231
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy.
Hamuro J; Kikuchi T; Takatsuki F; Suzuki M
Br J Cancer; 1996 Feb; 73(4):465-71. PubMed ID: 8595160
[TBL] [Abstract][Full Text] [Related]
12. Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts.
Zákány J; Chihara G; Fachet J
Int J Cancer; 1980 Mar; 25(3):371-6. PubMed ID: 7390659
[TBL] [Abstract][Full Text] [Related]
13. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
Takatsuki F; Miyasaka Y; Kikuchi T; Suzuki M; Hamuro J
Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
Suga T; Shiio T; Maeda YY; Chihara G
Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
[TBL] [Abstract][Full Text] [Related]
15. Effects of lentinan on colorectal carcinogenesis in mice with ulcerative colitis.
Mitamura T; Sakamoto S; Suzuki S; Yoshimura S; Maemura M; Kudo H
Oncol Rep; 2000; 7(3):599-601. PubMed ID: 10767375
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-mediated acute-phase transport protein production induced by lentinan.
Suga T; Maeda YY; Uchida H; Rokutanda M; Chihara G
Int J Immunopharmacol; 1986; 8(7):691-9. PubMed ID: 2430901
[TBL] [Abstract][Full Text] [Related]
17. Selective suppression of T-cell activity in tumor-bearing mice and its improvement by lentinan, a potent anti-tumor polysaccharide.
Haba S; Hamaoka T; Takatsu K; Kitagawa M
Int J Cancer; 1976 Jul; 18(1):93-104. PubMed ID: 780285
[TBL] [Abstract][Full Text] [Related]
18. The effect of lentinan on production of interleukin-1 by human monocytes.
Fruehauf JP; Bonnard GD; Herberman RB
Immunopharmacology; 1982 Oct; 5(1):65-74. PubMed ID: 6982258
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of schistosome granuloma formation. By lentinan--a T-cell adjuvant.
Byram JE; Sher A; DiPietro J; von Lichtenberg F
Am J Pathol; 1979 Feb; 94(2):201-22. PubMed ID: 371408
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of polysaccharide lentinan on MH-134 ascites hepatoma in C3H/He mice.
Moriyama M
Acta Med Okayama; 1982 Feb; 36(1):49-60. PubMed ID: 7064733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
